Last reviewed · How we verify
NCT07459439: VR-C-REHAB
Feasibility of Virtual Reality-assisted Ergometer Cycling in Addition to Regular Rehabilitation During Municipality-based Inpatient Rehabilitation Care
NA trial testing VR cycling in Older Adults (65 Years and Older) in 20 participants. Not yet recruiting.
1 June 2026
Quick facts
| Lead sponsor | Horsholm Municipality |
|---|---|
| Phase | NA |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | health services research |
| Enrollment | 20 |
| Start date | 9 March 2026 |
| Primary completion | 1 June 2026 |
| Estimated completion | 1 July 2026 |
| Sites | 2 locations across Denmark |
Drugs / interventions tested
- VR cycling
Conditions studied
- Older Adults (65 Years and Older) — all drugs for Older Adults (65 Years and Older) →
- Outpatient Treatment — all drugs for Outpatient Treatment →
- Rehabilitation Frail Elderly Subjects — all drugs for Rehabilitation Frail Elderly Subjects →
Sponsor
Horsholm Municipality
Who can join
65 and older, any sex, with Older Adults (65 Years and Older) or Outpatient Treatment. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
VR-C-REHAB is a single-group pilot and feasibility study examining the practicality of implementing virtual-reality-assisted ergometer cycling as an adjunct to usual municipal inpatient rehabilitation for older adults (≥65 years). Many individuals admitted to temporary inpatient care present with low physical activity levels and fluctuating motivation, reducing the achievable exercise dose. Virtual reality may enhance engagement, enjoyment, and adherence, but its feasibility in this setting must be evaluated before conducting a future effect trial. The primary objective is to determine whether participants can achieve an adequate exercise dose, defined as the proportion of completed VR-cycling sessions out of those offered (target: ≥75%). Secondary feasibility outcomes include recruitment rate, safety and acceptability, and total cycling time. Exploratory outcomes include change in the 10-Meter Walk Test and session-level motivation (0-10). The intervention consists of 20 minutes of VR-assisted cycling, three times weekly for up to four weeks, delivered alongside standard rehabilitation. Data are collected at baseline, during each session, and at completion. Analyses are descriptive, focusing on the precision of feasibility estimates. Progression criteria (Go/Amend/Stop) are based on adherence, recruitment, and safety. The results will inform the design and implementation of a subsequent controlled study.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07459439
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Older Adults (65 Years and Older)
Currently open trials in the same condition.
- NCT07393529 — A Pilot Randomized Controlled Trial of a Social Network Intervention · NA · recruiting
- NCT07520084 — Predictors of Climate Change Health Literacy in Older Individuals · recruiting
- NCT07034287 — Modifying the Geriatric Acute & Post-acute Care Coordination Program for Fall Prevention in the Emergency Department for · NA · recruiting
- NCT07235267 — Reliability and Validity of Tele-Assessment for Functional Performance in Older vs. Younger Adults · recruiting
- NCT07211750 — Integrated Care for Older Adults With Major Depression and Physical Multimorbidity - The I-CONNECT · NA · recruiting
Other Horsholm Municipality trials
Trials by the same sponsor.
- NCT05840315 — Feasibility of High Density Sit-to-stand Functional Resistance Training in Patients With Hip Fracture · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07459439 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Horsholm Municipality
- Last refreshed: 9 March 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07459439.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing